Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
PremiumPress ReleasesVoyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
1M ago
Voyager Therapeutics reports Q2 EPS (18c), consensus (41c)
Premium
The Fly
Voyager Therapeutics reports Q2 EPS (18c), consensus (41c)
1M ago
Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results
Premium
Press Releases
Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results
1M ago
Voyager Therapeutics Welcomes New CFO Nathan Jorgensen
PremiumCompany AnnouncementsVoyager Therapeutics Welcomes New CFO Nathan Jorgensen
3M ago
Voyager Therapeutics appoints Jorgensen as CFO
Premium
The Fly
Voyager Therapeutics appoints Jorgensen as CFO
3M ago
Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer
Premium
Press Releases
Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100